IL23A and psoriasis: Overall, IL-22 in human subjects seems to have weaker pro-inflammatory effects compared to the murine models, wherein IL-22 crucially contributes to the development of a psoriasis-like phenotype and to psoriatic skin inflammation induced by IL-23 or imiquimod.